To Compare Efficacy and Safety of CMAB007 and Xolair® in Patients With Chronic Spontaneous Urticaria
Clinical trial NCT06365879 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06365879
- Sponsor
- Taizhou Mabtech Pharmaceutical Co.,Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-18
- Primary completion
- 2026-01-29
- Enrollment
- 392
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.